Gilles de la Tourette syndrome (GTS) is a neurodevelopmental
condition characterised by tics and comorbid
behavioural problems, affecting predominantly
male patients. Tic severity typically fluctuates over time,
with a consistent pattern showing improvement after adolescence
in a considerable proportion of patients. Both tics
and behavioural co-morbidities have been shown to have
the potential to affect patients’ health-related quality of life
(HR-QoL) in children and adults with persisting symptoms.
In this study, we present the results of the first investigation
of HR-QoL in patients with Gilles de la Tourette syndrome
at the transition between adolescence and adulthood using
a disease-specific HR-QoL measure, the Gilles de la
Tourette Syndrome-Quality of Life-Children and Adolescents
scale. Our results showed that patients with GTS and
more severe co-morbid anxiety symptoms reported lower
HR-QoL across all domains, highlighting the impact of
anxiety on patient’s well-being at a critical stage of
development. Routine screening for anxiety symptoms is
recommended in all patients with GTS seen at transition
clinics from paediatric to adult care, to implement effective
behavioural and pharmacological interventions as
appropriate